Related Experiment Video
Updated: May 15, 2026

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
[Magnetic resonance imaging of dilated cardiomyopathy]
M D'Anastasi1, M Greif, M F Reiser
1Institut für Klinische Radiologie, Klinikum der Ludwig-Maximilians-Universität München, Campus Grosshadern, Deutschland. melvin.danastasi@med.uni-muenchen.de
Insights
Dilated cardiomyopathy (DCM), a common heart condition, often presents subtly, leading to underdiagnosis. Advanced imaging like MRI is crucial for assessing severity, guiding treatment, and improving patient outcomes.
Area of Science:
- Cardiology
- Medical Imaging
Context:
- Dilated cardiomyopathy (DCM) is the most prevalent cardiomyopathy, affecting 1 in 2,500 adults.
- Early-stage DCM often exhibits mild symptoms, suggesting its true prevalence may be underestimated.
- Clinical presentations vary widely, from subtle left ventricular dysfunction to severe congestive heart failure or sudden cardiac death.
Purpose:
- To highlight the diagnostic and prognostic significance of Magnetic Resonance Imaging (MRI) in Dilated Cardiomyopathy.
- To emphasize the role of MRI in quantifying ventricular function and evaluating myocardial structure for risk stratification and treatment guidance.
Summary:
- DCM is characterized by impaired global left ventricular function and is frequently associated with arrhythmias.
- Magnetic Resonance Imaging (MRI) is essential for precise quantification of ventricular function and regional wall motion abnormalities.
- MRI's detailed assessment of myocardial structure aids in risk stratification and therapy decisions for DCM patients.
Impact:
- Improved diagnostic accuracy for Dilated Cardiomyopathy.
- Enhanced risk stratification and personalized therapy guidance for patients with DCM.
- Potential for earlier intervention and improved management of heart failure and arrhythmias in DCM.
Abstract:
Dilated cardiomyopathy (DCM) is the most common type of cardiomyopathy with a prevalence of 1 out of 2,500 in adults. Due to mild clinical symptoms in the early phase of the disease, the true prevalence is probably even much higher. Patients present with variable clinical symptoms ranging from mild systolic impairment of left ventricular function to congestive heart failure. Even sudden cardiac death may be the first clinical symptom of DCM. The severity of the disease is defined by the degree of impairment of global left ventricular function. Arrhythmias, such as ventricular or supraventricular tachycardia, atrioventricular (AV) block, ventricular extrasystole and atrial fibrillation are common cardiac manifestations of DCM. Magnetic resonance imaging (MRI) plays an important role in the exact quantification of functional impairment of both ventricles and in the evaluation of regional wall motion abnormalities. With its excellent ability for the assessment of myocardial structure, it is becoming increasingly more important for risk stratification and therapy guidance.
Related Concept Videos
Imaging Studies for Cardiovascular System IV: CMRI
Cardiomyopathy II: Dilated Cardiomyopathy
Mitral Stenosis II: Clinical features and Diagnostic Tests
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Magnetic Resonance Imaging
Cardiomyopathy IV: Restrictive Cardiomyopathy

